GENE ONLINE|News &
Opinion
Blog

Feature
Keytruda Outcompetes Adcetris in Refractory or Relapsed Hodgkin Lymphoma Study
2020-03-03
Fight against COVID-19 Strengthens as Gilead Launches Phase III Trial for Remdesivir
2020-02-28
Relief for Patients as Baudax Bio’s Non-Opioid Analgesic Wins FDA Approval
2020-02-23
Peeking into the Future of Synthetic Biology and Gene Editing, an Exclusive Interview with Dr. George Church
2020-02-13
Understanding the Scientific Challenges in Combating the New Coronavirus
2020-02-11
Weekly Cover: Expansion of Samsung Biologics Projects into U.S. and Europe
2020-02-11
Antiviral Drug Developed By Emory University Shows Effectiveness against Coronaviruses
2020-02-05
February 4th 2020, World Cancer Day
2020-02-04
Weekly cover : Companies Developing 2019-nCoV Vaccine
2020-02-04
WHO Declares 2019-nCoV Outbreak, a Global Health Emergency
2020-01-31
Update On 2019 Novel Coronavirus (2019-nCov): The Latest Progress In Vaccine Development And Treatment
2020-01-30
Weekly Cover: LATEST Cell Therapy Trend in Taiwan& 2019-nCoV Outbreak
2020-01-23
The Rejuvenated Promise of RNA Therapeutics
2020-01-07
GeneOnline’s Top Mergers and Acquisitions of 2019
2019-12-31
The entire human genome decoded from a thousand year-old “chewing gum”
2019-12-30
1 55 56 57 58 59 60
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
EVENT
Scroll to Top